A phase 2 study of temsirolimus (CCI-779) in patients with soft tissue sarcomas
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.25928/fullpdf
Reference26 articles.
1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010
2. Phase III randomized, intergroup trial assessing imatinib mesylate at 2 dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033;Blanke;J Clin Oncol,2008
3. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial;Demetri;Lancet,2006
4. Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial;Hensley;Gynecol Oncol,2008
5. Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish group for research on sarcomas;Maurel;J Clin Oncol.,2009
Cited by 73 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. SAR-096: Phase II Clinical Trial of Ribociclib in Combination with Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS);Clinical Cancer Research;2023-11-15
2. Novel therapeutic strategies targeting UCP2 in uterine leiomyosarcoma;Pharmacological Research;2023-03
3. Uterine leiomyosarcoma;Diagnosis and Treatment of Rare Gynecologic Cancers;2023
4. Targeted therapies for soft tissue sarcomas and desmoid tumors;Bone and soft tissue sarcomas, tumors of the skin;2022-12-20
5. Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma;Frontiers in Oncology;2022-11-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3